# Biossom Investment Management

Biossom Investment Management is a Private Equity based in Beijing, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Beijing, China
- **Region:** Asia
- **Address:** Beijing, China
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** www.biossom.com.cn
- **LinkedIn:** linkedin.com/company/biosom

## Regulatory record

- **Reports private funds:** No

## About

Biossom Investment Management is a venture capital fund focused on bio-pharmaceuticals investments. It has made 12 investments, including a Series A - II investment in Pharmcube on September 17, 2018. The firm has 5 portfolio exits, with Biostar being its most recent exit on October 31, 2024.

## Questions

### What investment stages does Biossom Investment Management target?

Biossom covers a full venture lifecycle: early-stage seed and startup rounds, plus expansion and late-stage growth capital. The firm categorizes this as generalist venture, meaning it does not restrict itself to a single-point entry and can follow portfolio companies through multiple funding rounds. This multi-stage approach is documented in the firm's own strategy disclosures.

### Where is Biossom Investment Management's geographic focus?

The firm is headquartered in Beijing and concentrates its investment activity within China. No additional offices or cross-border mandates have been identified in public record. The single-jurisdiction focus aligns with the deep-local sourcing required for competitive early-stage venture in the Chinese market.

## Related profiles

- [Binyi Capital](https://altss.com/profile/binyi-capital)
- [Birch Equity Partners](https://altss.com/profile/birch-equity-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/biossom-investment-management

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology